SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
6960000 - NTII Revenue Matrix - Part 1 <pre> <b>Total Markets (000) John McCarthy-7/19/2003
695deletedJohn McCarthy-7/19/2003
6940000 - NTII Revenue Matrix 0000 - NTII Revenue Matrix <pre> <b> PotJohn McCarthy-7/19/2003
6930000 - NTII Revenue Matrix <pre> <b> Potential Memantine Market &John McCarthy-7/19/2003
6920000 - N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cJohn McCarthy-7/17/2003
6912003 - [AD][800 000 new patients every year in Europe] Monday, 18 August 2003 John McCarthy-7/17/2003
6902003 - The Eleventh International Congress Chicago, USA All presentations - aJohn McCarthy-7/17/2003
6892003 - [Memantine][Wernicke-Korsakoff syndrome.] 1: Med Arh. 2003;57(3):149-50.John McCarthy-7/17/2003
6880000 - How are lysosomes and peroxisomes produced? Lysosomes are the cells'John McCarthy-7/16/2003
6872003 - Thursday, 21 August 2003 - Clinical Approach to Dementia Thursday, 21 AuJohn McCarthy-7/16/2003
6862003 - Tuesday, 19 August 2003 - Memantine/Donepezil Dual Therapy Tuesday, 19 AJohn McCarthy-7/16/2003
6852003 - Tuesday, 19 August 2003 - Memantine and Donepezil Tuesday, 19 August 200John McCarthy-7/16/2003
6842003 - Tuesday, 19 August 2003 - Nursing Home Patients Tuesday, 19 August 2003 John McCarthy-7/16/2003
6832003 - Thursday, 21 August 2003 - Behavioral Effects of Subchronic Memantine TreJohn McCarthy-7/16/2003
6822003 - Thursday, 21 August 2003 - Restores Okadaic Acid-Induced Changes ThursdaJohn McCarthy-7/16/2003
6812003 - Thursday, 21 August 2003 - Levels of the Amyloid Beta This presentation John McCarthy-7/16/2003
6802003 - Tuesday, 19 August 2003 - Treatment of Patients with Vascular Dementia TJohn McCarthy-7/16/2003
6792003 - Tuesday, 19 August 2003 - Neuroprotection in Animal Models This presentJohn McCarthy-7/16/2003
6782003 - Tuesday, 19 August 2003 - 24-Week, Open-Label Extension This presentatioJohn McCarthy-7/16/2003
6772003 - [O.T.][NC-758] Source: Thomas Jefferson University Neuroscientists at tJohn McCarthy-5/16/2003
6761993 - [USA Patent] patft.uspto.govJohn McCarthy-5/16/2003
6752003 - [Dementia Stats in U.K.] England 634,000 Scotland 60,600 Northern IrelJohn McCarthy-5/15/2003
6742003 - [Efficacy, safety and cost of new drugs acting on the central nervous sysJohn McCarthy-5/14/2003
6732003 - [EBIXA][NICE] Monday 31st March 2003 FURTHER ACTION TO TACKLE POST-CODEJohn McCarthy-5/14/2003
6722002 - [Oct][Memantine & Risperidone Trial] Martin Schaefer, M.D. Charite, John McCarthy-5/11/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News